Though ADHD is typically treated with stimulants like Adderall, people may opt for non-stimulants because they come with ...

Patients seeking medication management for attention-deficit/hyperactivity disorder, or ADHD, usually choose between two medications—methylphenidate or amphetamine ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...

The centrally acting alpha2-adrenergic agonist is approved for patients 6 years of age and older. HealthDay News — The US Food and Drug Administration has approved once-daily Onyda XR (clonidine ...

NEW YORK (Reuters Health) - L-acetylcarnitine (LAC), a natural substance devoid of side effects, may be considered an alternative to stimulants to control attention deficit hyperactivity disorder ...

Recent research from this team expands on the associations found in this study, including a study that suggested teens with a history of taking both stimulant or non-stimulant medications for ADHD are ...

Mentavi's clinically validated, asynchronous ADHD assessment - recently published in the Journal ... "With national discussions underway about stimulant and non-stimulant treatments, and with ...

When child psychiatrists gather, presentations on ADHD almost always orbit around the use of stimulants—methylphenidate and amphetamine in their many formulations. At this year’s Texas Society of ...